Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$6.31
+5.2%
$8.27
$5.16
$3,756.00
$2.87M-0.23167,810 shs157,293 shs
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$0.95
+2.5%
$2.11
$0.67
$16.25
$2.40M1.711.80 million shs691,586 shs
NIMU
Non-Invasive Monitoring Systems
$0.00
-22.6%
$0.01
$0.00
$0.02
$630K0.985,819 shs2,000 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.62
+10.5%
$2.40
$2.10
$14.50
$3.38M0.07687,045 shs6.25 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
+5.17%+1.61%-16.53%-47.47%-99.73%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
+2.46%+2.51%-15.18%-62.89%-87.66%
NIMU
Non-Invasive Monitoring Systems
0.00%-41.43%-68.46%+24.24%-65.25%
Venus Concept Inc. stock logo
VERO
Venus Concept
+10.55%+19.09%+13.42%+15.93%-66.85%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
1.0556 of 5 stars
0.05.00.00.03.00.80.0
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.2779 of 5 stars
0.02.00.00.02.00.00.6
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
1.4213 of 5 stars
0.02.00.00.03.33.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.00
N/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
0.00
N/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A($983.43) per shareN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
$2.56M0.96N/AN/A$1.84 per share0.52
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/A($0.01) per shareN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.06N/AN/A$4.30 per share0.61
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$22.60M-$56.60N/AN/AN/AN/A-544.87%N/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
-$3.70M-$13.53N/AN/A-210.82%-54.73%-38.63%8/13/2025 (Estimated)
NIMU
Non-Invasive Monitoring Systems
-$110KN/A0.00N/AN/AN/A-251.43%N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$76.30N/AN/A-81.26%-752.29%-54.52%8/12/2025 (Estimated)

Latest NIMU, GCTK, VERO, and NAOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A-$3.98N/A-$3.98N/A$1.02 million
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/14/2025Q1 2025
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$20.40N/A-$0.67N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/AN/AN/AN/AN/A
NIMU
Non-Invasive Monitoring Systems
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.03
4.85
4.85
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
N/A
0.47
0.22
NIMU
Non-Invasive Monitoring Systems
N/A
0.03
0.03
Venus Concept Inc. stock logo
VERO
Venus Concept
7.91
1.28
0.79

Institutional Ownership

CompanyInstitutional Ownership
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
16.39%
NIMU
Non-Invasive Monitoring Systems
0.12%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
12.91%
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
6.30%
NIMU
Non-Invasive Monitoring Systems
28.80%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
5480,000416,000Not Optionable
Nanovibronix, Inc. stock logo
NAOV
Nanovibronix
202.58 million2.42 millionNot Optionable
NIMU
Non-Invasive Monitoring Systems
3154.81 million110.23 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

Venus Concept Inc News (VERO) - Investing.com
Venus Concept Shares Soar on Sale of Hair Business

New MarketBeat Followers Over Time

Media Sentiment Over Time

GlucoTrack stock logo

GlucoTrack NASDAQ:GCTK

$6.31 +0.31 (+5.17%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$6.16 -0.15 (-2.46%)
As of 08:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Nanovibronix stock logo

Nanovibronix NASDAQ:NAOV

$0.95 +0.02 (+2.46%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$0.92 -0.03 (-2.74%)
As of 08:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Non-Invasive Monitoring Systems OTCMKTS:NIMU

$0.0041 0.00 (-22.64%)
As of 06/30/2025 10:30 AM Eastern

Non-Invasive Monitoring Systems, Inc. does not have significant operations. Previously, it was involved in the research, development, manufacture, marketing, and sale of non-invasive, motorized, and whole body periodic acceleration platforms. The company was incorporated in 1980 and is based in Miami, Florida.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.62 +0.25 (+10.55%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$2.62 0.00 (-0.19%)
As of 08:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.